Dialysis Access Treatment Devices | Market Insights | Japan | 2019
Dialysis access treatment trends differ significantly in Japan compared to those in other regions, with physicians choosing short AVF maturation times and strongly favoring hemodialysis over other treatments typically used for ESRD. However, the Japanese market continues to face a number of impediments, including biennial reimbursement cuts and more limited device availability.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Japan across a 10-year period.